South Korea · Delayed Price · Currency is KRW Kolon Life Science Statistics
Total Valuation
KOSDAQ:102940 has a market cap or net worth of KRW 729.15 billion. The enterprise value is 822.24 billion.
| Market Cap | 729.15B |
| Enterprise Value | 822.24B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:102940 has 13.09 million shares outstanding. The number of shares has increased by 14.58% in one year.
| Current Share Class | 13.09M |
| Shares Outstanding | 13.09M |
| Shares Change (YoY) | +14.58% |
| Shares Change (QoQ) | -11.32% |
| Owned by Insiders (%) | 17.14% |
| Owned by Institutions (%) | 0.25% |
| Float | 7.60M |
Valuation Ratios
The trailing PE ratio is 30.54.
| PE Ratio | 30.54 |
| Forward PE | n/a |
| PS Ratio | 3.49 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 71.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.08, with an EV/FCF ratio of -29.31.
| EV / Earnings | 32.94 |
| EV / Sales | 3.93 |
| EV / EBITDA | 30.08 |
| EV / EBIT | 46.79 |
| EV / FCF | -29.31 |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.18.
| Current Ratio | 0.64 |
| Quick Ratio | 0.28 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 3.79 |
| Debt / FCF | -3.70 |
| Interest Coverage | 2.26 |
Financial Efficiency
Return on equity (ROE) is 6.81% and return on invested capital (ROIC) is 2.99%.
| Return on Equity (ROE) | 6.81% |
| Return on Assets (ROA) | 1.65% |
| Return on Invested Capital (ROIC) | 2.99% |
| Return on Capital Employed (ROCE) | 2.36% |
| Weighted Average Cost of Capital (WACC) | 5.44% |
| Revenue Per Employee | 491.72M |
| Profits Per Employee | 58.73M |
| Employee Count | 426 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.98 |
Taxes
In the past 12 months, KOSDAQ:102940 has paid 795.76 million in taxes.
| Income Tax | 795.76M |
| Effective Tax Rate | 3.09% |
Stock Price Statistics
The stock price has increased by +118.86% in the last 52 weeks. The beta is 0.17, so KOSDAQ:102940's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +118.86% |
| 50-Day Moving Average | 60,126.00 |
| 200-Day Moving Average | 43,662.25 |
| Relative Strength Index (RSI) | 46.76 |
| Average Volume (20 Days) | 49,957 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:102940 had revenue of KRW 208.98 billion and earned 24.96 billion in profits. Earnings per share was 1,824.00.
| Revenue | 208.98B |
| Gross Profit | 55.78B |
| Operating Income | 17.57B |
| Pretax Income | 25.76B |
| Net Income | 24.96B |
| EBITDA | 27.34B |
| EBIT | 17.57B |
| Earnings Per Share (EPS) | 1,824.00 |
Balance Sheet
The company has 10.64 billion in cash and 103.73 billion in debt, with a net cash position of -93.09 billion or -7,111.55 per share.
| Cash & Cash Equivalents | 10.64B |
| Total Debt | 103.73B |
| Net Cash | -93.09B |
| Net Cash Per Share | -7,111.55 |
| Equity (Book Value) | 584.03B |
| Book Value Per Share | 46,258.72 |
| Working Capital | -61.75B |
Cash Flow
In the last 12 months, operating cash flow was 10.21 billion and capital expenditures -38.26 billion, giving a free cash flow of -28.05 billion.
| Operating Cash Flow | 10.21B |
| Capital Expenditures | -38.26B |
| Depreciation & Amortization | 9.76B |
| Net Borrowing | -17.42B |
| Free Cash Flow | -28.05B |
| FCF Per Share | -2,143.14 |
Margins
Gross margin is 26.69%, with operating and profit margins of 8.41% and 11.94%.
| Gross Margin | 26.69% |
| Operating Margin | 8.41% |
| Pretax Margin | 12.32% |
| Profit Margin | 11.94% |
| EBITDA Margin | 13.08% |
| EBIT Margin | 8.41% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:102940 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.58% |
| Shareholder Yield | -14.58% |
| Earnings Yield | 3.42% |
| FCF Yield | -3.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KOSDAQ:102940 has an Altman Z-Score of 0.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.64 |
| Piotroski F-Score | 6 |